Article 1 to 2 out of 2 concerning Bausch & Lomb Inc.
Bausch & Lomb and Galapagos sign agreement to collaborate on ophthalmic disease research(04/14/2008) Bausch & Lomb and Galapagos NV announced that they have entered into a collaborative research agreement. Bausch & Lomb will have the exclusive option to license select Galapagos compounds as development candidates for therapeutic uses in ophthalmic ...
Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use(08/30/2006) Bausch & Lomb and Talecris Biotherapeutics announced that Talecris has granted an exclusive worldwide license to Bausch & Lomb for recombinant Plasmin technology for use in ophthalmology. The companies will co-develop rPlasmin, a recombinant ...
Top
